• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希腊阿提卡地区的家庭门诊肠外抗生素治疗(OPAT)。

Outpatient parenteral antibiotic therapy (OPAT) at home in Attica, Greece.

机构信息

SOS Doctors, 1 Ipirou Street, Athens, 10433, Greece.

出版信息

Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):2957-61. doi: 10.1007/s10096-012-1647-1. Epub 2012 Jun 2.

DOI:10.1007/s10096-012-1647-1
PMID:22653635
Abstract

Outpatient parenteral antibiotic therapy (OPAT) is considered to be a cost-effective and safe alternative treatment strategy to hospitalization. We retrospectively evaluated data regarding the demographic and treatment characteristics of patients that sought medical advice from a network of physicians performing house-call visits and who received OPAT at home during a 17-month period (May 2009 to September 2010) in Attica, Greece. A total of 91 patients (69.2 % females) received intravenous antibiotic therapy at home during the evaluated period. The mean age [± standard deviation (SD)] of the patients was 85.3 (± 9) years. The main indications were pneumonia [46 patients (50.5 %)], urinary tract infection [25 (27.5 %)], and gastrointestinal tract infection [9 (9.9 %)]. Of the patients, 76.4 % received a beta-lactam, 17.5 % a fluoroquinolone, 15.3 % an imidazole, 8.7 % an aminoglycoside, and 5.4 % a lincosamide. The cure rate was 72.5 % and mortality was 27.5 %. The mean duration (± SD) of intravenous antibiotic treatment was 4.7 (± 3.3) days. The mean cost per patient was 637 and was comparable to the mean cost if the patient were to be hospitalized for the same infection. There was significant clinical effectiveness of OPAT at home in this mainly elderly population, at an acceptable cost.

摘要

门诊患者的肠外抗生素治疗(OPAT)被认为是一种具有成本效益且安全的替代住院治疗策略。我们回顾性评估了在希腊阿提卡地区的一个医生网络中,接受上门就诊并在家中接受 OPAT 治疗的患者的人口统计学和治疗特征的数据。在 17 个月的时间内(2009 年 5 月至 2010 年 9 月),共有 91 名患者(69.2%为女性)接受了静脉内抗生素治疗。患者的平均年龄(±标准差(SD))为 85.3(±9)岁。主要适应证为肺炎[46 例(50.5%)]、尿路感染[25 例(27.5%)]和胃肠道感染[9 例(9.9%)]。在这些患者中,76.4%接受了β-内酰胺类药物,17.5%接受了氟喹诺酮类药物,15.3%接受了咪唑类药物,8.7%接受了氨基糖苷类药物,5.4%接受了林可酰胺类药物。治愈率为 72.5%,死亡率为 27.5%。静脉内抗生素治疗的平均持续时间(±SD)为 4.7(±3.3)天。每位患者的平均费用为<欧元>637 欧元,如果患者因相同感染住院,费用相当。在这个主要由老年人组成的人群中,OPAT 在家中具有显著的临床疗效,而且成本可以接受。

相似文献

1
Outpatient parenteral antibiotic therapy (OPAT) at home in Attica, Greece.希腊阿提卡地区的家庭门诊肠外抗生素治疗(OPAT)。
Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):2957-61. doi: 10.1007/s10096-012-1647-1. Epub 2012 Jun 2.
2
Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.门诊静脉用抗生素治疗 (OPAT) 的临床疗效、成本分析和患者接受度:谢菲尔德(英国)OPAT 服务十年来的经验。
Int J Antimicrob Agents. 2018 Jan;51(1):26-32. doi: 10.1016/j.ijantimicag.2017.03.016. Epub 2017 Jun 30.
3
Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States.美国德克萨斯州休斯顿的两家县级医院中,使用一次性弹性连续输注泵进行自我管理的门诊抗生素输注治疗的特点、安全性和成本效益分析。
J Clin Pharm Ther. 2022 Feb;47(2):211-217. doi: 10.1111/jcpt.13550. Epub 2021 Oct 26.
4
A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.门诊肠外抗生素治疗(OPAT)的成本分析:亚洲视角
Int J Antimicrob Agents. 2009 Jan;33(1):46-51. doi: 10.1016/j.ijantimicag.2008.07.016. Epub 2008 Sep 26.
5
Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.比利时门诊接受胃肠外抗生素治疗患者的临床特征及治疗结果:一项单中心试点研究
Acta Clin Belg. 2020 Aug;75(4):275-283. doi: 10.1080/17843286.2019.1608396. Epub 2019 Apr 25.
6
Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.成人门诊胃肠外抗生素治疗(OPAT)项目的成本分析。加拿大一家教学医院及卫生部视角。
Pharmacoeconomics. 2000 Nov;18(5):451-7. doi: 10.2165/00019053-200018050-00004.
7
Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.门诊静脉用抗生素治疗(OPAT)的临床疗效和成本效益:英国视角。
J Antimicrob Chemother. 2009 Dec;64(6):1316-24. doi: 10.1093/jac/dkp343. Epub 2009 Sep 19.
8
Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry.门诊使用达托霉素进行胃肠外抗生素治疗:来自患者登记处的见解
Int J Clin Pract. 2008 Aug;62(8):1183-7. doi: 10.1111/j.1742-1241.2008.01824.x.
9
Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: a safe and effective model.感染性心内膜炎的自我管理门诊胃肠外抗菌治疗(S-OPAT):一种安全有效的模式。
Eur J Intern Med. 2015 Mar;26(2):131-6. doi: 10.1016/j.ejim.2015.01.001. Epub 2015 Jan 14.
10
Clinical outcomes of a veterans affairs outpatient antimicrobial treatment program.退伍军人事务部门诊抗菌治疗项目的临床结果
South Med J. 2013 Jun;106(6):345-9. doi: 10.1097/SMJ.0b013e3182967e8f.

引用本文的文献

1
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review.门诊患者的肠外抗菌治疗的现状和挑战:叙事性综述。
J Antimicrob Chemother. 2024 Sep 3;79(9):2083-2102. doi: 10.1093/jac/dkae177.
2
Economic burden of skin and skin structure infections due to Gram-positive bacteria in patients on hospital at home-based outpatient parenteral antibiotic therapy (OPAT).居家门诊静脉用抗生素治疗(OPAT)患者中革兰阳性菌所致皮肤和皮肤结构感染的经济负担。
Rev Esp Quimioter. 2023 Jun;36(3):291-301. doi: 10.37201/req/134.2022. Epub 2023 Apr 5.
3
Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union/European Economic Area, 1997-2017.

本文引用的文献

1
Update and overview of outpatient parenteral antimicrobial therapy regulations and reimbursement.门诊患者的肠外抗菌药物治疗规范和报销的更新与概述。
Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S216-9. doi: 10.1086/653522.
2
Outpatient parenteral antimicrobial therapy today.今日门诊患者的肠外抗菌治疗。
Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S198-208. doi: 10.1086/653520.
3
Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.门诊静脉用抗生素治疗(OPAT)的临床疗效和成本效益:英国视角。
社区内四环素类、磺胺类和甲氧苄啶以及其他抗菌药物的消费情况,欧盟/欧洲经济区,1997-2017 年。
J Antimicrob Chemother. 2021 Jul 26;76(12 Suppl 2):ii45-ii59. doi: 10.1093/jac/dkab177.
4
Cost-analysis of inpatient and outpatient parenteral antimicrobial therapy in orthopaedics: A systematic literature review.骨科住院和门诊胃肠外抗菌治疗的成本分析:一项系统文献综述
World J Clin Cases. 2019 Jul 26;7(14):1825-1836. doi: 10.12998/wjcc.v7.i14.1825.
5
Patient house calls in Attica and Thessaloniki, Greece (2005-2015): a model for out-of-hospital multispecialty emergency medicine.希腊阿提卡和塞萨洛尼基的上门患者服务(2005-2015 年):院外多专科急诊医学的一种模式。
BMC Health Serv Res. 2018 Apr 27;18(1):304. doi: 10.1186/s12913-018-3111-0.
6
Clinical and cost-effectiveness, safety and acceptability of ommunity ntraenous ntibiotic ervice models: CIVAS systematic review.社区静脉抗生素服务模式的临床及成本效益、安全性与可接受性:CIVAS系统评价
BMJ Open. 2017 Apr 20;7(4):e013560. doi: 10.1136/bmjopen-2016-013560.
7
Outpatient parenteral antimicrobial therapy.门诊胃肠外抗菌治疗
Can J Infect Dis Med Microbiol. 2013 Spring;24(1):9-11. doi: 10.1155/2013/205910.
J Antimicrob Chemother. 2009 Dec;64(6):1316-24. doi: 10.1093/jac/dkp343. Epub 2009 Sep 19.
4
Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin.欧洲革兰氏阳性菌感染的门诊胃肠外抗菌治疗(OPAT)的进展以及达托霉素的潜在影响
J Antimicrob Chemother. 2009 Sep;64(3):447-53. doi: 10.1093/jac/dkp245. Epub 2009 Jul 7.
5
Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study.老年患者的门诊胃肠外抗生素治疗:一项意大利多中心观察性研究。
J Chemother. 2009 Apr;21(2):193-8. doi: 10.1179/joc.2009.21.2.193.
6
Avoiding hospital admission through provision of hospital care at home: a systematic review and meta-analysis of individual patient data.通过提供居家医院护理避免住院:对个体患者数据的系统评价和荟萃分析
CMAJ. 2009 Jan 20;180(2):175-82. doi: 10.1503/cmaj.081491.
7
Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis.中重度社区获得性肺炎患者早期转换为口服治疗:一项荟萃分析。
Drugs. 2008;68(17):2469-81. doi: 10.2165/0003495-200868170-00005.
8
Limited role for outpatient parenteral antibiotic therapy for community-acquired pneumonia.门诊胃肠外抗生素治疗对社区获得性肺炎作用有限。
Respirology. 2008 Nov;13(6):893-6. doi: 10.1111/j.1440-1843.2008.01370.x.
9
An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service.一张用于识别与门诊静脉抗生素治疗(OPAT)服务相关风险的门诊静脉抗生素治疗(OPAT)地图。
J Antimicrob Chemother. 2008 Jul;62(1):177-83. doi: 10.1093/jac/dkn152. Epub 2008 Apr 12.
10
Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients.社区获得性肺炎门诊治疗与住院治疗的比较:低风险患者的一项随机试验
Ann Intern Med. 2005 Feb 1;142(3):165-72. doi: 10.7326/0003-4819-142-3-200502010-00006.